Dr. Gufford's research interests include various aspects of drug disposition and action with a particular focus on drug-drug, and natural product-drug interactions. Brandon has more than a decade of experience evaluating drug disposition and interactions as a clinician, academic investigator, and clinical pharmacokineticist. Dr. Gufford has a wide range of drug metabolism and pharmacokinetics experience including in vitro assessments, clinical study design and optimization, pharmacogenetic considerations, and application of advanced modelling and simulation approaches. Brandon has experience with PK, PD, and PK/PD analyses of clinical data from Phase I-IV clinical trials with an emphasis on early phase drug development. Dr. Gufford has maintained an adjunct appointment with the Division of Clinical Pharmacology since 2018.